Cleveland Clinic Appoints Chairman of The Taussig Cancer Institute
Brian J. Bolwell, MD, an International Leader in Bone Marrow Transplantation and Malignant Hematology, to Head One of the Nation’s Top Programs
July 28, 2011
Cleveland Clinic has appointed Brian J. Bolwell, MD, as chairman of the Taussig Cancer Institute. Dr. Bolwell, a 24-year Cleveland Clinic veteran, will lead one of the country’s largest and most respected cancer programs.
Dr. Bolwell is an international leader in the management of hematologic malignancies and bone marrow transplantation. His research in disorders of blood and bone marrow cells has resulted in significant clinical advances and expanded the scope of stem cell transplantation for patients who were previously ineligible for this life-saving treatment.
Dr. Bolwell has also held many leadership positions both at Cleveland Clinic and on many national and regional societies and organizations. He is currently Vice Chairman of the Office of Professional Staff Affairs, Executive Director of Strategic Space Planning, a member of the Cleveland Clinic Board of Governors, and he was recently appointed to the Executive Committee of the Case Comprehensive Cancer Center.
“Brian’s clinical and institutional leadership roles provide the Taussig Cancer Institute with a valuable combination of insight and experience that will continue to move the Institute forward as a national center of excellence,” said Joseph Hahn, MD, Chief of Staff. “Brian has the respect of his colleagues in Taussig and across the organization thanks to his proven record of success, academic excellence, innovation and dedication to his team and the Cleveland Clinic.”
Dr. Bolwell became the Interim Chair of the Taussig Cancer Institute in 2010. He has served as Director of the Bone Marrow Transplant Program since 1988 and as Chairman of the Department of Hematologic Oncology and Blood Disorders since 2006. He also served as President of the Professional Staff of the Cleveland Clinic Foundation from 2004-2005. Dr. Bolwell is Professor of Medicine at the Cleveland Clinic Lerner School of Medicine, and he joined Cleveland Clinic in 1987.
“This is an exciting time in the world of oncology, and I’m honored to be leading such a dedicated, caring team of people who put patients first every day in all that they do,” Dr. Bolwell said. “This team that has already accomplished so much, including having 42 of America’s Top Doctors on our staff, being ranked in the top 10 in the nation by U.S.News & World Reports for two consecutive years, and we’re the home of the Scott Hamilton CARES Initiative, which provides important support programs for our patients.”
Under Dr. Bolwell’s direction, Cleveland Clinic opened a new, 44-bed state-of-the-art bone marrow transplant and leukemia floor in August 2009 with central hepa filtration and special patient and family accommodations. He also oversaw the development of a new cell processing laboratory designed for the unique needs of bone marrow transplantation.
Dr. Bolwell completed his undergraduate education at Harvard University and attended Case Western Reserve School of Medicine. His internal medicine training was at University Hospitals of Cleveland and he completed a Hematology/Oncology fellowship in the Hospital of the University of Pennsylvania in Philadelphia. He is an elected member of the Executive Committee of the Center for International Blood and Marrow Research (CIBMTR). He is Chairman of the Board of Trustees of the Ohio Hematopoietic Stem Cell Transplant Consortium, a position he has held for 13 years. Dr. Bolwell has published extensively in the field of bone marrow transplantation and hematological malignancies, including over 300 articles and abstracts and two textbooks. He is an ad hoc reviewer for the Journal of Clinical Oncology, Bone Marrow Transplantation, Blood, Annals of Internal Medicine, and many other scientific periodicals.
“I look forward to working with the team to continue our efforts to improve outcomes and enhance our support services for patients; perform state of the art clinical and translational research as we strive to eradicate all forms of cancer; and ensure that the Taussig Cancer Institute is a great place to work,” added Dr. Bolwell.
For more information on the Taussig Cancer Institute at Cleveland Clinic, visit clevelandclinic.org/cancer, or call the Cancer Answer Line at 866.223.8100.
About Cleveland Clinic
Celebrating its 90th anniversary, Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. It was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. U.S.News & World Report consistently names Cleveland Clinic as one of the nation’s best hospitals in its annual “America’s Best Hospitals” survey. About 2,800 full-time salaried physicians and researchers and 11,000 nurses represent 120 medical specialties and subspecialties. Cleveland Clinic Health System includes a main campus near downtown Cleveland, nine community hospitals and 15 Family Health Centers in Northeast Ohio, Cleveland Clinic Florida, the Lou Ruvo Center for Brain Health in Las Vegas, Cleveland Clinic Canada, and opening in 2013, Cleveland Clinic Abu Dhabi. In 2010, there were 4 million visits throughout the Cleveland Clinic health system and 155,000 hospital admissions. Patients came for treatment from every state and from more than 100 countries. Visit us at www.clevelandclinic.org. Follow us at www.twitter.com/ClevelandClinic.
Cleveland Clinic News Service is available to provide video interviews and B-roll.